1. Home
  2. CTBI vs TBPH Comparison

CTBI vs TBPH Comparison

Compare CTBI & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Community Trust Bancorp Inc.

CTBI

Community Trust Bancorp Inc.

HOLD

Current Price

$56.45

Market Cap

1.0B

Sector

Finance

ML Signal

HOLD

Logo Theravance Biopharma Inc.

TBPH

Theravance Biopharma Inc.

HOLD

Current Price

$18.08

Market Cap

993.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTBI
TBPH
Founded
1903
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
993.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CTBI
TBPH
Price
$56.45
$18.08
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
$59.00
$27.80
AVG Volume (30 Days)
66.4K
475.1K
Earning Date
01-16-2026
11-10-2025
Dividend Yield
3.75%
N/A
EPS Growth
17.49
N/A
EPS
5.17
0.58
Revenue
$261,447,000.00
$80,327,000.00
Revenue This Year
$21.01
$70.78
Revenue Next Year
$6.33
N/A
P/E Ratio
$10.93
$32.24
Revenue Growth
13.97
27.12
52 Week Low
$44.60
$7.90
52 Week High
$61.55
$20.33

Technical Indicators

Market Signals
Indicator
CTBI
TBPH
Relative Strength Index (RSI) 41.82 48.75
Support Level $59.58 $18.51
Resistance Level $58.69 $19.22
Average True Range (ATR) 1.26 0.59
MACD -0.55 -0.08
Stochastic Oscillator 3.91 41.22

Price Performance

Historical Comparison
CTBI
TBPH

About CTBI Community Trust Bancorp Inc.

Community Trust Bancorp Inc is a bank holding company. The Bank owns all the capital stock of one commercial bank and one trust company, serving small and mid-sized communities in eastern, north-eastern, central, and southcentral Kentucky, southern West Virginia, and north-eastern Tennessee. Through its subsidiaries, the Bank is engaged in commercial and personal banking and trust and wealth management activities, which include accepting time and demand deposits; making secured and unsecured loans to corporations, individuals, and others; providing cash management services to corporate and individual customers; issuing letters of credit; renting safe deposit boxes; and providing funds transfer services.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: